PDCD1 and Hepatitis: Hepatitis occurred after median 12 weeks of PD-1 inhibitor treatment (range 1–98 weeks), 6 weeks of ipilimumab treatment (range 1–16 weeks) and 6 weeks of combination therapy (range 1–13 weeks).